Matrix metalloproteinase 9 expression: new regulatory elements

Area of Science:

• Molecular Biology
• Ophthalmology
• Cell Biology

Background:

• Retinal ganglion cell apoptosis is linked to matrix metalloproteinase 9 (MMP-9) and extracellular matrix changes.
• Abnormal MMP-9 expression is implicated in glaucomatous alterations, highlighting the need to understand its regulation in glaucoma pathogenesis.

Purpose of the Study:

• To investigate the role of 3'-untranslated regions (3'-UTR) and microRNAs (miRNAs) in regulating MMP-9 expression.
• To identify specific miRNAs and their binding sites within the MMP-9 3'-UTR involved in gene expression control.

Main Methods:

• In vitro mutagenesis and a luciferase reporter system were employed to identify regulatory elements in the MMP-9 3'-UTR.
• Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze miRNA expression.
• miRNA inhibitors and mimics were utilized to confirm the regulatory role of identified miRNAs, including miR-340.

Main Results:

• Specific miRNA target sites within the MMP-9 3'-UTR were identified, mediating MMP-9 expression.
• The study confirmed the regulatory function of miR-340 in controlling MMP-9 expression in optic nerve astrocytes and 293 T cells.

Conclusions:

• A novel miRNA-mediated regulatory mechanism for MMP-9 expression has been elucidated.
• This finding provides new insights into the pathogenesis of glaucoma and potential therapeutic targets.